🔎 Trials Near Me

Utama › Pendarahan Serebral › Texas

Kajian klinikal Pendarahan Serebral di Texas

6 kajian untuk Pendarahan Serebral sedang mencari peserta di lokasi di Texas.

Bandar di Texas

Teks kajian rasmi (Bahasa Inggeris)

Minimally Invasive Neuroendoscopic Ultra-Early Targeted ICH Evacuation

  • University of Texas Medical Branch, Galveston
  • Houston Methodist Hospital, Houston
  • Memorial Hermann Texas Medical Center, Houston
  • dan 1 lagi
Mengambil peserta
Umur 18 hingga 80 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07260916

Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

  • Houston Methodist Research Institute, Houston
  • UTHealth, Houston
  • University of Texas Health Science Center at San Antonio, San Antonio
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT04916210

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2

  • Memorial Hermann Memorial City Medical Center, Houston
  • Memorial Hermann-Texas Medical Center, Houston
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07227246

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

  • UT Southwestern Medical Center, Dallas
  • University of Texas Health Science Center San Antonio, San Antonio
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 100 · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06402968

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

  • Houston Methodist Hospital, Houston
  • Memorial Hermann Texas Medical Center, Houston
  • University of Texas Health Science Center San Antonio, San Antonio
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Mei 2026 · NCT03907046

Effect of the Stellate Ganglion Block on the Retinal Microcirculation

  • UT Southwestern Medical Center, Dallas
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Nov 2025 · NCT06797752

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.